AMA Research, a global market research and consulting organization, have released a new study titled "Oligonucleiotide Synthesis market - Global outlook to 2027". Industries constant focus on reducing the operational cost and increased attention on core business, and need to improve scalability are expected to shape the Global Oligonucleiotide Synthesis market to grow at a CAGR of 13.9% to aggregate USD8.4 Billion by 2027.
The End User, such as Academic & Research Institutes, is boosting the Oligonucleiotide Synthesis market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
The Products made from Oligonucleiotide, such as Oligonucleotide-based Drugs, is boosting the Oligonucleiotide Synthesis market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
According to Analyst at AMA Research, the Global Oligonucleiotide Synthesis market will experience significant growth during the forecast period due to potential opportunities lying in the market such as . Some of the important driving forces are Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications and Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies.
Oligonucleotide synthesis is referred to as the chemical synthesis of proportionally short fragments of the nucleic acids with stated chemical structure. The technique is especially useful in the practice of the current laboratory, as it provides rapid and inexpensive access to the custom-made oligonucleotides of the sequence as desired. Oligonucleotide synthesis is basically an integral part of the several ongoing genetic research studies. Growing investments in genetic research are anticipated for boosting demand for a custom synthesis of various classes of oligos which includes aptamers, decoys, immunostimulatory, antisense, miRNA and siRNA.
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global Oligonucleiotide Synthesis market by Type (Custom Oligonucleotides and Pre-designed Oligonucleotides), by Application (Research, Diagnostics and Therapeutics) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key trends (current and future) of the market